reglab/statecodes huggingface dataset:
Ohio Administrative Code › Title 4729 - State Board of Pharmacy › Chapter 4729-35 - Drug Repository Programs › Section 4729-35-03 - Donating drugs

Current through all regulations passed and filed through July 1, 2024
(A) The following may donate a dangerous
			 drug, pursuant to the eligibility requirements of rule
			 4729-35-04
			 of the Administrative Code, to a pharmacy, hospital, or nonprofit clinic that
			 elects to participate in the drug repository program:
(1) A licensed terminal distributor of
			 dangerous drugs.
(2) A licensed
			 wholesale distributor of dangerous drugs.
(3) A person who was legally dispensed a
			 dangerous drug pursuant to a patient-specific drug order.
Ohio Administrative Code › Title 4729 - State Board of Pharmacy › Chapter 4729-35 - Drug Repository Programs › Section 4729-35-04 - Eligible drugs

Current through all regulations passed and filed through July 1, 2024
All dangerous drugs, except controlled substances and drug
				samples, may be donated to a pharmacy, hospital, or nonprofit clinic that
				elects to participate in the drug repository program if the drugs meet all of
				the following requirements:
(A) The
			 drugs are in their original sealed and tamper-evident unit dose packaging. The
			 packaging must be unopened except that the drugs packaged in single unit doses
			 may be accepted and dispensed when the outside packaging is opened if the
			 single unit dose packaging is undisturbed. If the drugs were packaged by a
			 pharmacy the name of the pharmacy and any other pharmacy identifiers must be
			 removed from the packaging prior to dispensing to a recipient patient. This may
			 be accomplished by removing the drug from the pharmacy packaging or by removing
			 the name from the outside packaging of a multiple dose unit dose packaging
			 system.
(B) The drugs have been in
			 the possession of a licensed healthcare professional and not in the possession
			 of the ultimate user.
(C) The
			 drugs have been stored according to Federal Food and Drug Administration
			 storage requirements.
(D) The
			 drugs must have an expiration date of six months or greater.
(E) The packaging must list the lot number
			 and expiration date of the drug.
(F) The drugs must not have any physical
			 signs of tampering or adulteration.
(G) The drug packaging must not have any
			 physical signs of tampering.
(H)
			 All confidential patient information must have been removed from the drug
			 packaging.
Ohio Administrative Code › Title 4729 - State Board of Pharmacy › Chapter 4729-35 - Drug Repository Programs › Section 4729-35-05 - Eligibility requirements to receive drugs

Current through all regulations passed and filed through July 1, 2024
A pharmacy, hospital, or nonprofit clinic that elects to
				participate in the drug repository program must determine if a person is
				eligible to receive drugs. A person must meet the following requirements to
				become an eligible recipient of drugs from the drug repository program:
(A) Is a resident of Ohio, and
(B)
(1) Has
			 no reasonable financial means to pay for the drug prescribed; or,
(2) Is a patient of a nonprofit clinic.
Ohio Administrative Code › Title 4729 - State Board of Pharmacy › Chapter 4729-35 - Drug Repository Programs › Section 4729-35-06 - Donor form

Current through all regulations passed and filed through July 1, 2024
(A) Each donor must sign a form stating that
			 the donor is the owner of the drug and intends to voluntarily donate the drug
			 to the drug repository program. The donor form must be completed prior to any
			 donation and include at least the following:
(1) The name of the person that was
			 originally dispensed the drugs, or the name of the terminal distributor of
			 dangerous drugs or wholesale distributor of dangerous drugs that owns the
			 drugs.
(2) The signature of the
			 donor, which may include the person designated by durable power of attorney, a
			 guardian, an individual responsible for the care and well-being of a patient,
			 or the signature of the responsible person or his/her designee from a terminal
			 distributor of dangerous drugs or a wholesale distributor of dangerous drugs.
(3) The date the form was signed.
Ohio Administrative Code › Title 4729 - State Board of Pharmacy › Chapter 4729-35 - Drug Repository Programs › Section 4729-35-07 - Recipient form

Current through all regulations passed and filed through July 1, 2024
Prior to receiving donated drugs from a drug repository
				program, each recipient must sign a form stating they understand the immunity
				provisions of the program pursuant to division (B) of section
				3715.872 of the Revised Code.
Replaces: 4729-35-07
Ohio Administrative Code › Title 4729 - State Board of Pharmacy › Chapter 4729-35 - Drug Repository Programs › Section 4729-35-08 - Record keeping

Current through all regulations passed and filed through July 1, 2024
(A) Donor forms must be maintained for a
			 minimum of three years by a terminal distributor of dangerous drugs, a
			 wholesale distributor of dangerous drugs, or an institutional facility.
(B) Recipient forms must be
			 maintained for a minimum of three years by a pharmacy, hospital, or nonprofit
			 clinic.
(C) An invoice must be
			 created by the donor location, which includes a terminal distributor of
			 dangerous drugs, a wholesale distributor of dangerous drugs, or an
			 institutional facility where the donor resides. The invoice must include at
			 least the following information:
(1) The name
			 and address of the donor location.
(2) The brand name of the drug donated, or
			 the generic name and list either the name of the manufacturer or the national
			 drug code number (NDC#).
(3) The
			 strength of the drug.
(4) The
			 quantity of the drug.
(5) The date
			 the drug was sent to a pharmacy, hospital, or nonprofit clinic.
(6) The name and address of the recipient
			 pharmacy, hospital, or nonprofit clinic.
Ohio Administrative Code › Title 4729 - State Board of Pharmacy › Chapter 4729-35 - Drug Repository Programs › Section 4729-35-09 - Handling fee

Current through all regulations passed and filed through July 1, 2024
A pharmacy, a hospital, or a nonprofit
				clinic may charge the recipient of a donated drug a handling fee up to twenty
				dollars to cover restocking and dispensing costs. If a drug repository program
				chooses to charge a handling fee, then the fees collected in any given year
				shall not exceed the program's total restocking and dispensing costs for that
				given year.
Replaces: 4729-35-09
Ohio Administrative Code › Title 4729 - State Board of Pharmacy › Chapter 4729-36 - Charitable Pharmacy › Section 4729-36-01 - Definitions

Current through all regulations passed and filed through July 1, 2024
As used in Chapter 4729-36 of the Administrative Code:
(A) "Charitable pharmacy" means a pharmacy
			 that meets all of the following requirements:
(1) Holds a terminal distributor of dangerous
			 drug license issued under section
			 4729.54 of the Revised
			 Code;
(2) Is exempt from federal
			 taxation pursuant to
			 26 U.S.C.
			 501(a) and (c)(3)
									(5/28/2015); and
(3) Is not a hospital as defined in section
			 3727.01 of the Revised
			 Code.
Ohio Administrative Code › Title 4729 - State Board of Pharmacy › Chapter 4729-36 - Charitable Pharmacy › Section 4729-36-02 - Licensure of a charitable pharmacy

Current through all regulations passed and filed through July 1, 2024
A pharmacy that desires to be a charitable pharmacy shall
				maintain a terminal distributor of dangerous drug license. An application for
				licensure must include the following:
(A) A completed application designating the
			 desire to become a charitable pharmacy;
(B) Documents to support the exemption from
			 federal taxation pursuant to
			 26 U.S.C.
			 501(a) and (c)(3)
								(5/28/2015); and
(C) The fee for the appropriate category of
			 licensure.
Ohio Administrative Code › Title 4729 - State Board of Pharmacy › Chapter 4729-36 - Charitable Pharmacy › Section 4729-36-03 - Requirements of a charitable pharmacy

Current through all regulations passed and filed through July 1, 2024
A charitable pharmacy is considered to be a pharmacy pursuant
				to section 4729.01 of the Revised Code and
				must follow all federal and state laws, rules, and regulations that pertain to
				pharmacies and the practice of pharmacy, including, but not limited to, the
				following:
(A) Minimum standards for
			 a pharmacy pursuant to rule
			 4729-9-02
			 of the Administrative Code;
(B)
			 Security requirements pursuant to 4729-9-05 of the Administrative Code;
(C) Security and control of the
			 sample drugs pursuant to rule
			 4729-9-11
			 of the Administrative Code;
(D)
			 Record keeping pursuant to rules
			 4729-5-27 and
			 4729-9-22
			 of the Administrative Code;
(E)
			 Serial numbering of prescriptions pursuant to rule
			 4729-5-19
			 of the Administrative Code;
(F)
			 Prescription filing pursuant to rule
			 4729-5-09 of
			 the Administrative Code;
(G)
			 Confidentiality of patient records pursuant to 4729-5-29 of the Administrative
			 Code;
(H) Labeling pursuant to
			 4729-5-16 of the Administrative Code;
(I) Patient profiles pursuant to rule
			 4729-5-18 of the
			 Administrative Code;
(J)
			 Prospective drug utilization review pursuant to 4729-5-20 of the Administrative
			 Code;
(K) Patient counseling
			 pursuant to rule
			 4729-5-22 of
			 the Administrative Code;
(L)
			 Reporting of theft or loss of dangerous drugs pursuant to 4729-9-15 of the
			 Administrative Code; and
(M)
			 Storage of adulterated drugs pursuant to rule
			 4729-9-17
			 of the Administrative Code.
Ohio Administrative Code › Title 4729 - State Board of Pharmacy › Chapter 4729-36 - Charitable Pharmacy › Section 4729-36-04 - Sample drug distribution to a charitable pharmacy

Current through all regulations passed and filed through July 1, 2024
(A) An eligible sample drug shall only be
			 distributed directly to a charitable pharmacy by a:
(1) Manufacturer;
(2) Manufacturer's representative;
(3) Wholesale distributor of dangerous drugs
			 acting on behalf of a manufacturer; or
(4) Prescriber practicing in a location that
			 is licensed as a terminal distributor of dangerous drugs
			 unless exempt from licensure pursuant to sections
			 4729.51 and
			 4729.541 of the Revised
			 Code.
Ohio Administrative Code › Title 4729 - State Board of Pharmacy › Chapter 4729-36 - Charitable Pharmacy › Section 4729-36-05 - Eligibility requirements for sample drugs received by a charitable pharmacy

Current through all regulations passed and filed through July 1, 2024
(A) The sample drug is in the original
			 container in which it was placed by its manufacturer and the container is
			 clearly marked sample;
(B) Prior
			 to being furnished, the sample drug has been stored under the proper conditions
			 to prevent deterioration or contamination;
(C) The sample drug is clearly marked with an
			 expiration date and lot number;
(D) The sample drug is not expired; and
(E) The sample drug is not a
			 controlled substance.
Ohio Administrative Code › Title 4729 - State Board of Pharmacy › Chapter 4729-36 - Charitable Pharmacy › Section 4729-36-06 - Dispensing a sample drug by a charitable pharmacy

Current through all regulations passed and filed through July 1, 2024
(A) A pharmacist in a charitable pharmacy
			 must have a valid prescription prior to dispensing a sample drug to a patient
			 pursuant to rules
			 4729-5-21
			 and
			 4729-5-30
			 of the Administrative Code.
(B)
			 The charitable pharmacy must determine the eligibility requirements for a
			 patient to receive a sample drug.
(C) The sample drug is dispensed to the
			 patient free of charge.
(D) The
			 sample drug may be dispensed:
(1) In the
			 original container in which it was placed by its manufacturer where the
			 container is clearly marked as sample; or
(2) By removing the sample drug from the
			 original container only if the prescription label on the appropriate container,
			 pursuant to rule
			 4729-9-02
			 of the Administrative Code, clearly states that the drug dispensed is a sample
			 drug.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-2 - Licensing of Pharmacists › Section 4729:1-2-01 - Criteria for licensure by examination

Current through all regulations passed and filed through July 1, 2024
(A) Pursuant to sections
			 4729.07 and
			 4729.13 of the Revised Code,
			 pharmacist licensure by examination shall consist of the "North American
			 Pharmacist Licensure Examination" (NAPLEX) and the "Multistate Pharmacy
			 Jurisprudence Examination" (MPJE) administered by the
			 national association of boards of pharmacy (NABP).
(1)
									Unless otherwise
			 approved by the board,
									the minimum passing score on each examination
			 shall be determined by NABP.
(a) Any candidate who fails to receive a
			 passing score  on the NAPLEX examination shall make application and
			 remit the fee established by the state board of pharmacy for
			 re-examination.
(b) Any candidate
			 who fails to receive a passing score
			  on the MPJE jurisprudence
			 examination shall make application and remit the fee established by the state
			 board of pharmacy for re-examination.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-2 - Licensing of Pharmacists › Section 4729:1-2-02 - Criteria for licensure by reciprocity

Current through all regulations passed and filed through July 1, 2024
(A) An applicant seeking licensure as a
			 pharmacist by reciprocity shall comply with all the following:
(1) Be at least eighteen years of
			 age.
(2) Obtain a degree in
			 pharmacy from a school of pharmacy approved by the state board of
			 pharmacy.
(3) Have met the
			 applicable practical experience requirements by either:
(a) Successfully graduating after December
			 31, 2006 with a doctor of pharmacy degree (Pharm.D.) from a school of pharmacy
			 approved by the state board of pharmacy; or
(b) Obtaining a total of at least one
			 thousand seven hundred and forty hours of documented supervised practical
			 experience in Ohio or any other state or jurisdiction in which the credentials
			 are at least the equivalent of those required by this state at the time the
			 experience was obtained. If the reciprocating state or jurisdiction requires
			 less than the required hours, the board may grant internship credit for
			 practice as a pharmacist.
(4) Hold an active license or registration to
			 practice pharmacy, which is in good standing, in a state or jurisdiction in
			 which the credentials are at least the equivalent of those required by this
			 state. Certification of these credentials shall be conducted by the national association of boards of
			 pharmacy (NABP) .
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-2 - Licensing of Pharmacists › Section 4729:1-2-03 - Examination application for licensure as a pharmacist

Current through all regulations passed and filed through July 1, 2024
(A) Each person seeking to apply to take the
			 examinations for licensure as a pharmacist shall submit the required
			 application materials and fees to the national association of boards of
			 pharmacy (NABP) and the following to the state board of pharmacy:
(1) A completed application form as provided
			 by the board;
(2) Required fee, including any transaction fee as required by section
			 125.18 of the Revised
			 Code; and
(3) Either of the
			 following:
(a) A certificate of education
			 completed and certified by an approved school of pharmacy documenting the
			 successful graduation of the applicant with a doctor of pharmacy degree
			 obtained after December 31, 2006; or
(b) The required hours of supervised
			 practical experience pursuant to rule
			 4729:2-2-05 of the
			 Administrative Code, and either:
(i) A
			 certificate of education completed and certified by an approved school of
			 pharmacy documenting the successful graduation of the applicant; or
(ii) Certification provided by the national association of boards of pharmacy
			 documenting the applicant has
											 established educational equivalency by obtaining a "Foreign
			 Pharmacy Graduate Examination Commission" (FPGEC) certificate and evidence of
			 successful completion of the "Test of English as a Foreign Language,
			 Internet-based test (TOEFL iBT)" pursuant to rule
			 4729:1-2-04 of the
			 Administrative Code.
(4)
									Any other
			 information or documentation as determined by the board.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-2 - Licensing of Pharmacists › Section 4729:1-2-04 - Successful completion of the Test of English as a Foreign Language, Internet-based Test

Current through all regulations passed and filed through July 1, 2024
Successful completion of the "Test of
				English as a Foreign Language, Internet-based test" (TOEFL iBT) shall be the
				following minimum scores or higher:
(A)
									Writing: twenty-four;
(B)
									Speaking:
				twenty-six;
(C)
									Listening: twenty-one; and
(D)
									Reading:
				twenty-two.
Replaces: 4729-5-34
Effective: 9/15/2017
Five Year
				Review (FYR) Dates: 09/15/2022
Promulgated Under:
				119.03
Statutory
				Authority: 4729.26
Rule
				Amplifies: 4729.08
Prior
				Effective Dates: 1/1/06, 1/1/11
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-2 - Licensing of Pharmacists › Section 4729:1-2-05 - Criminal records check for pharmacists

Current through all regulations passed and filed through July 1, 2024
(A)
								Pursuant to
			 section 4729.071 of the Revised Code, an
			 applicant seeking an initial license as a pharmacist by examination or
			 reciprocity must first submit fingerprint impressions to the Ohio bureau of
			 criminal identification and investigation (BCI&I) for a criminal records
			 check.
(B)
								Pursuant to section
			 4776.02 of the Revised Code, the
			 criminal records check performed by BCI&I shall consist of both a BCI&I
			 criminal records check and a federal bureau of investigation (FBI) criminal
			 records check. BCI&I shall send the results of the BCI&I and FBI
			 criminal records checks directly to the state board of
			 pharmacy.
(C)
								The state board of pharmacy requires that the criminal
			 records check:
(1)
									Be based on electronic fingerprint impressions that are
			 submitted directly to BCI&I from a WebCheck provider agency or ink
			 impressions. The state board of pharmacy may accept the results of a criminal
			 records check based on ink impressions only in the following
			 circumstances:
(a)
										Readable electronic fingerprint impressions cannot be
			 obtained or are rejected by either BCI&I or FBI;
(b)
										The applicant is
			 from out-of-state;
(c)
										The applicant's home address is seventy-five miles or
			 more from the nearest WebCheck location.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-2 - Licensing of Pharmacists › Section 4729:1-2-06 - Pharmacist change of name, address or employment

Current through all regulations passed and filed through July 1, 2024
(A) A pharmacist, who has a legal change of
			 name, shall notify the board of pharmacy, in a manner determined by the board,
			 within thirty days from the effective date of such change. Such notification of
			 a name change shall be accompanied by one of the following:
(1) A notarized affidavit;
(2) A certified copy of a court record;
(3) A certified copy of a marriage
			 certificate;
(4)
									A government-issued identification card which reflects
			 the pharmacist's name change; or
(5)
									Any other
			 documentation as approved by the board.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-2 - Licensing of Pharmacists › Section 4729:1-2-07 - Pharmacist licensure and renewal

Current through all regulations passed and filed through July 1, 2024
(A)
								Except as
			 provided in paragraph (B) of this rule, a pharmacist license issued by the
			 state board of pharmacy in accordance with Chapter 4729. of the Revised Code
			 entitles the individual to whom it is issued to practice as a pharmacist until
			 the next renewal date.
(B)
								An initial pharmacist license issued by the state board
			 of pharmacy on or after the first of May of every odd-numbered year in
			 accordance with Chapter 4729. of the Revised Code entitles the individual to
			 whom it is issued to practice as a pharmacist until the renewal date
			 immediately following the next required renewal date.
(C)
								A pharmacist
			 license shall be renewed on the fifteenth day of September of every
			 odd-numbered year.
(D)
								An individual who fails to renew their license by the
			 fifteenth day of September of every odd-numbered year shall not engage in the
			 practice of pharmacy until a valid license is issued by the
			 board.
(E)
								In accordance with section
			 4729.15 of the Revised Code, the
			 renewal fee shall be two hundred fifty dollars and any transaction fee as
			 required by section 125.18 of the Revised
			 Code.
(F)
								In accordance with section
			 4729.15 of the Revised Code, a
			 pharmacist renewing a license that expired less than three years shall pay the
			 renewal fee plus a penalty of thirty-seven dollars and fifty
			 cents.
(G)
								In accordance with section
			 4729.13 of the Revised Code, a
			 pharmacist who fails to renew a license within three years may reinstate the
			 license by:
(1)
									Successfully completing the required examinations pursuant
			 to rule
			 4729:1-2-01 of the
			 Administrative Code; or
(2)
									Meeting the criteria for licensure by reciprocity
			 pursuant to rule
			 4729:1-2-02 of the
			 Administrative Code.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-2 - Licensing of Pharmacists › Section 4729:1-2-08 - Veteran and military family provisions related to pharmacist licensure

Current through all regulations passed and filed through July 1, 2024
(A)
								Renewal of an expired license.
(1)
									In accordance
			 with section 5903.10 of the Revised Code, a
			 holder of an expired license shall be granted a renewal of the license by the
			 state board of pharmacy at the usual cost without penalty and without
			 re-examination if not otherwise disqualified because of mental or physical
			 disability and if either of the following applies:
(a)
										The license was
			 not renewed because of the holder's service in the armed
			 forces.
(b)
										The license was not renewed because the holder's spouse
			 served in the armed forces of the United States or a reserve component of the
			 armed forces and the service resulted in the holder's absence from this
			 state.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-2 - Licensing of Pharmacists › Section 4729:1-2-09 - Expedited pharmacist licensure for members of the military and spouses who are licensed in another jurisdiction

Current through all regulations passed and filed through July 1, 2024
(A)
								As used in this
			 rule:
(1)
									"Military duty" has the same meaning as in section
			 4743.041
			 of the Revised Code.
(2)
									"In good standing" means an applicant to which both the
			 following apply:
(a)
										Has not been denied a license, registration or
			 certificate by any public agency or licensing agency; and
(b)
										Does not have a
			 license, registration or certificate limited, suspended, or revoked by any
			 public agency or licensing agency.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-2 - Licensing of Pharmacists › Section 4729:1-2-10 - Emeritus pharmacists

Current through all regulations passed and filed through July 1, 2024
(A)
								As used in this
			 rule:
(1)
									"Emeritus pharmacist" means an individual who meets all the
			 following:
(a)
										Is currently or has been licensed to practice pharmacy in
			 this state for at least ten years;
(b)
										Is retired from
			 the practice of pharmacy;
(c)
										Is in good standing;
(d)
										Is at least sixty
			 years old; and
(e)
										Has applied for an emeritus designation in accordance
			 with this rule.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-3 - Practice › Section 4729:1-3-01 - Pharmacist administration of diagnostic tests

Current through all regulations passed and filed through July 1, 2024
(A)
								A pharmacist may
			 administer clinical laboratory improvement amendments (CLIA) waived diagnostic
			 laboratory testing provided the following conditions are met:
(1)
									The pharmacy or
			 facility licensed as a terminal distributor of dangerous drugs is certified by
			 the United States department of health and human services (HHS), as a clinical
			 laboratory through the CLIA;
(2)
									The pharmacy or
			 facility licensed as a terminal distributor of dangerous drugs has obtained a
			 CLIA certificate of waiver from HHS; and
(3)
									The responsible
			 person of the terminal distributor of dangerous drugs and the terminal
			 distributor of dangerous drugs ensures and documents that all pharmacists
			 conducting CLIA waived tests pursuant to this rule receive appropriate training
			 to conduct testing in a safe and effective manner.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-3 - Practice › Section 4729:1-3-02 - Immunization administration

Current through all regulations passed and filed through July 1, 2024
(A) A course in the administration of
			 immunizations developed pursuant to division (B)(1) of section
			 4729.41 of the Revised Code
			 shall meet the following requirements:
(1) The
			 instructor shall be a licensed health care professional and have the
			 appropriate education and experience to teach a course in the administration of
			 immunizations.
(2) The content must
			 meet the standards established for such courses by the centers for disease
			 control and prevention in the public health service of the United States
			 department of health and human services.
(3) The course shall be conducted by an
			 accreditation council for pharmacy education (ACPE) accredited
			 provider.
(4) The course must be a
			 minimum of five hours in length and include the following:
(a) A review of immunology that includes a
			 discussion of the body's immune system reaction to immunizations.
(b) A review of each immunization
			 
										recommended by the committee on
			 immunization practices of centers for disease control and prevention in the
			 United States department of health and human services (8/5/2022) that
			 includes the following:
(i) Disease states
			 associated with the immunization;
(ii) Type or nature of activity of the
			 immunization;
(iii) Administration
			 schedules;
(iv) Routes of
			 administration;
(v) Injection
			 sites;
(vi) Dosages;
(vii) Monitoring and treatment of the patient
			 for adverse reactions, including the use of diphenhydramine and
			 epinephrine;
(viii) Patient
			 populations;
(ix) Precautions and
			 contraindications; and
(x) Proper
			 storage requirements for the immunization.
(c) A review of sterile technique in
			 injectable dosage preparation and administration.
(d) A minimum of one hour of instruction and
			 physical participation in administration techniques.
(e) A review of the proper disposal
			 procedures for contaminated needles and immunizations.
(f) A review of the proper procedures for
			 accidental needle sticks.
(5) The course must provide a method to
			 evaluate the successful comprehension of the content.
(6) The course must provide a method to
			 demonstrate the participant has successfully completed the course.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-3 - Practice › Section 4729:1-3-03 - Administration of dangerous drugs by injection

Current through all regulations passed and filed through July 1, 2024
(A)
								A pharmacist
			 licensed under Chapter 4729. of the Revised Code may administer, by injection,
			 any of the following dangerous drugs if the dangerous drug that is to be
			 administered has been prescribed by a physician and the individual to whom the
			 dangerous drug was prescribed has an ongoing relationship with the physician,
			 an advanced practice registered nurse who has entered into a standard care
			 arrangement with the physician, or a physician assistant who has entered into a
			 supervision agreement with the physician:
(1)
									An opioid
			 antagonist used for treatment of drug addiction and administered in a
			 long-acting or extended-release form. An opioid antagonist may also be
			 administered for the treatment of alcohol dependence in accordance with
			 approved labeling by the United States food and drug
			 administration.
(2)
									An antipsychotic drug administered in a long-acting or
			 extended-release form.
(3)
									Hydroxyprogesterone caproate for pregnant
			 women.
(4)
									Medroxyprogesterone acetate for non-pregnant
			 women.
(5)
									Cobalamin, to include: cyanocobalamin, hydroxocobalamin
			 or any other vitamin B12 injection approved by the United States food and drug
			 administration.
(6)
									Any other dangerous drugs authorized for pharmacist
			 administration pursuant to section
			 4729.45 of the Revised
			 Code.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-3 - Practice › Section 4729:1-3-04 - Dispensing of naloxone by pharmacists

Current through all regulations passed and filed through July 1, 2024
(A)
								A pharmacist may
			 dispense naloxone without a prescription to either of the following in
			 accordance with a protocol specified in paragraph (B) of this rule:
(1)
									An individual who
			 there is reason to believe is experiencing or at risk of experiencing an
			 opioid-related overdose;
(2)
									A family member, friend, or other person in a position
			 to assist an individual who there is reason to believe is at risk of
			 experiencing an opioid-related overdose.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-3 - Practice › Section 4729:1-3-05 - Therapeutic diabetic shoes

Current through all regulations passed and filed through July 1, 2024
(A)
								Pursuant to
			 section 4779.02 of the Revised Code, a
			 pharmacist may fit and measure individuals for therapeutic diabetic shoes and
			 shoe inserts and may dispense those shoes and shoe inserts.
(B)
								A pharmacist
			 shall not provide any other services that are authorized under Chapter 4779. of
			 the Revised Code.
Replaces: 4729-5-23
Effective: 4/1/2019
Five Year Review
				(FYR) Dates: 04/01/2024
Promulgated Under:
				119.03
Statutory
				Authority: 4729.26
Rule
				Amplifies: 4779.02
Prior
				Effective Dates: 10/05/2015
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-3 - Practice › Section 4729:1-3-06 - Dispensing of epinephrine autoinjectors by pharmacists

Current through all regulations passed and filed through July 1, 2024
(A)
								A pharmacist may dispense an epinephrine autoinjector
			 without a prescription to either of the following in accordance with a protocol
			 specified in paragraph (B) of this rule:
(1)
									An individual who
			 there is reason to believe is experiencing or at risk of experiencing
			 anaphylaxis if the pharmacy affiliated with the pharmacist has a record of
			 previously dispensing epinephrine to the individual in accordance with a
			 prescription issued by a licensed health professional authorized to prescribe
			 drugs; or
(2)
									An individual acting on behalf of a qualified entity,
			 as defined in section
			 3728.01 of the Revised
			 Code.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-3 - Practice › Section 4729:1-3-07 - Dispensing nicotine replacement therapy by pharmacists

Current through all regulations passed and filed through July 1, 2024
(A)
								As used in this rule, "nicotine replacement therapy"
			 means a drug, including a dangerous drug, that delivers small doses of nicotine
			 to an individual for the purpose of aiding in tobacco cessation or smoking
			 cessation including for the cessation of alternative nicotine delivery systems,
			 such as e-cigarettes.
(B)
								A pharmacist may dispense nicotine replacement therapy
			 to individuals who are eighteen years old or older and seeking to quit using
			 tobacco-containing products in accordance with paragraph (C) of this
			 rule.
(C)
								For a pharmacist to be authorized to dispense nicotine
			 replacement therapy under this rule, the pharmacist shall do both of the
			 following:
(1)
									Successfully complete a course on nicotine replacement
			 therapy that is taught by a provider that is accredited by the accreditation
			 council for pharmacy education, or another provider approved by the state board
			 of pharmacy, and that meets requirements established in paragraph (H) of this
			 rule; and
(2)
									Practice in accordance with a physician-authorized
			 protocol that meets the requirements of paragraph (D) of this
			 rule.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-4 - Disciplinary Action Definitions › Section 4729:1-4-01 - Disciplinary actions

Current through all regulations passed and filed through July 1, 2024
(A) As used in this rule:
(1) "Dishonesty" means any action by a
			 licensee, registrant or applicant to include, but is not limited to, making any
			 statement that deceives, misrepresents or misleads, or be a party to or an
			 accessory to any fraudulent or deceitful practice or transaction in the
			 practice of pharmacy or in the operation or conduct of a pharmacy.
(2) "Unprofessional conduct" has the same
			 meaning as defined in division (C) of section
			 4729.16 of
			 the Revised Code and shall also include conduct that is detrimental to the best
			 interests of the public, including conduct that endangers the health, safety or
			 welfare of a patient or client. Such conduct shall include, but not be limited
			 to, the following acts: coercion, intimidation, harassment, sexual harassment,
			 improper use of private health information, threats, degradation of character,
			 indecent or obscene conduct, and theft.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-4 - Disciplinary Action Definitions › Section 4729:1-4-02 - Duty to report

Current through all regulations passed and filed through July 1, 2024
(A) As used in this rule:
(1) "Error in dispensing" or "prescription
			 error" means an act or omission of clinical significance relating to the
			 dispensing of a drug. An error in dispensing may be considered a violation of
			 division (A)(2) of section
			 3715.52 and
			 section
			 3715.64
			 of the Revised Code.
(2) "Harm"
			 means impairment of the physical, emotional, or psychological function or
			 structure of the body and/or pain resulting therefrom.
(3) "Intervention" means a change in therapy
			 or active medical/surgical treatment.
(4) "Intervention necessary to sustain life"
			 means cardiovascular and respiratory support (e.g., CPR, defibrillation,
			 intubation, etc.).
(5) "Reckless
			 behavior" means a person who acts recklessly or who is reckless. A person acts
			 recklessly when, with heedless indifference to the consequences, the person
			 disregards a substantial and unjustifiable risk that the person's conduct is
			 likely to cause a certain result or is likely to be of a certain nature. A
			 person is reckless with respect to circumstances when, with heedless
			 indifference to the consequences, the person disregards a substantial and
			 unjustifiable risk that such circumstances are likely to exist.
(6) "Unprofessional conduct" has the same
			 meaning as defined in paragraph (A) of rule
			 4729:1-4-01
			 of the Administrative Code.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-5 - Continuing Education › Section 4729:1-5-01 - Pharmacist continuing education - definitions

Current through all regulations passed and filed through July 1, 2024
As used in Chapter 4729:1-5 of the Administrative Code:
(A) "A.C.P.E." means the accreditation
			 council for pharmacy education.
(B)
								"Board approved pharmacy practice-specific specialty
			 certification program" means a practice-specific specialty certification
			 program that meets one of the following:
(1)
									The program is
			 offered by the board of pharmacy specialties (BPS); or
(2)
									The program is
			 offered by the specialty pharmacy certification board (SPCB);
			 or
(3)
									A program approved by the board that consist of the
			 following:
(a)
										Periodic recertification examinations;
(b)
										Documentation by
			 the certification program that the pharmacist is currently certified by the
			 program; and
(c)
										Other requirements as determined by the board.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-5 - Continuing Education › Section 4729:1-5-02 - Continuing education requirements for pharmacists

Current through all regulations passed and filed through July 1, 2024
(A)
(1)
									Except as provided in paragraph (A)(2) of this rule,
			 three C.E.U.s (thirty contact hours) of approved continuing education shall be
			 completed by a pharmacist licensed in accordance with Chapter 4729. of the
			 Revised Code prior to the renewal of the pharmacist's license. At least 0.2
			 C.E.U.s of the total required C.E.U.s must be obtained in pharmacy
			 jurisprudence and at least 0.2 C.E.U.s of the total required C.E.U.s must be
			 obtained in patient or medication safety. The C.E.U.s must be obtained within a
			 period that is no more than two years prior to September fifteenth of the year
			 in which a pharmacist's license must be renewed.
(2)
									A pharmacist who
			 obtains initial licensure by reciprocity or examination shall not have to
			 complete the continuing education requirements for the initial licensure period
			 prior to the renewal of that pharmacist's license.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-5 - Continuing Education › Section 4729:1-5-03 - Veteran and military family provisions related to continuing education

Current through all regulations passed and filed through July 1, 2024
(A) Extension of
			 continuing education requirements.
(1) In
			 accordance with section
			 5903.12 of the Revised Code, the
			 state board of pharmacy shall grant extension periods and waivers for the
			 completion of continuing education requirements for active duty veteran members
			 and the spouses of active duty veterans. If a current pharmacist or their
			 spouse is called to active duty for military service, the time period allowed
			 for completion of any continuing education requirements will be extended by the
			 amount of time that the pharmacist or the pharmacist's spouse was on active
			 duty.
(2) Upon receiving the
			 application and proper documentation, the board's executive director or the
			 director's designee shall extend the continuing education reporting period by
			 an amount of time equal to the total number of months that the licensee or
			 their spouse spent on active duty during the current reporting period. For
			 purposes of this division, any portion of a month served on active duty shall
			 be considered one full month.
(3)
			 The licensee shall submit proper documentation certifying the active duty
			 service and the length of that active duty service. Documentation required to
			 obtain an extension or waiver pursuant to paragraph (A)(1) of this rule will be
			 published on the state board of pharmacy's website:
www.pharmacy.ohio.gov
.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-6 - Consult Agreements with Physicians › Section 4729:1-6-01 - Definitions - consult agreements

Current through all regulations passed and filed through July 1, 2024
(A)
								"Certified nurse practitioner," "certified
			 nurse-midwife," "clinical nurse specialist," and "standard care arrangement"
			 have the same meanings as in section
			 4723.01 of the
			 Revised Code.
(B)
								"Collaborating physician" means a physician who has
			 entered into a standard care arrangement with a clinical nurse specialist,
			 certified nurse-midwife, or certified nurse practitioner.
(C)
								"Communication
			 between a pharmacist and practitioner acting under a consult agreement," as
			 used in division (D)(6) of section
			 4729.39
			 of the Revised Code, means any of the following:
(1)
									Electronic mail
			 that confirms delivery;
(2)
									Interoperable electronic medical records
			 system;
(3)
									Facsimile that confirms delivery;
(4)
									Electronic
			 prescribing system;
(5)
									Electronic pharmacy record system;
(6)
									Documented verbal
			 communication; or
(7)
									Any other method of documented notification as outlined
			 in the consult agreement between the pharmacist and
			 practitioner.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-6 - Consult Agreements with Physicians › Section 4729:1-6-02 - Consult agreements

Current through all regulations passed and filed through July 1, 2024
(A) Requirements of a consult agreement.
(1) A consult agreement shall include all of
			 the following:
(a) Identification of the
			 practitioner(s) and pharmacist(s) authorized to enter
			 into the agreement. This may include:
(i)
			 Individual names of practitioners and pharmacists;
(ii)
											Practitioner
			 or pharmacist practice groups; or
(iii) Identification based on institutional
			 credentialing or privileging.
Ohio Administrative Code › Title 4729:1 - Licensing and Consult Agreements › Chapter 4729:1-6 - Consult Agreements with Physicians › Section 4729:1-6-03 - Standards for managing drug therapy

Current through all regulations passed and filed through July 1, 2024
(A) A managing pharmacist shall prescribe in
			 accordance with a valid prescriber-patient relationship. This includes, but is
			 not limited to, the following:
(1) Reviewing a
			 thorough history of the patient;
(2) Except as provided in
			 paragraphs
			 (F) and (G)(2) of this rule, conducting an initial consultation with the
			 patient via in-person meeting, video conference,
			 or by telephone;
(3) Ordering
			 tests and evaluation of test results in accordance with section
			 4729.39
			 of the Revised Code;
(4)
			 Prescribing medication in accordance this division of the Administrative Code,
			 ruling out the existence of any recognized contraindications;
(5) Consulting with the authorizing
			 practitioner on the consult agreement when necessary;
			 and
(6) Documenting these steps in
			 the patient's medical record.
Ohio Administrative Code › Title 4729:2 - Pharmacy Interns › Chapter 4729:2-2 - Licenses › Section 4729:2-2-01 - Licensure as a pharmacy intern

Current through all regulations passed and filed through July 1, 2024
(A) A license as a pharmacy intern shall only
			 be issued for the purpose of allowing those individuals who intend to become
			 licensed pharmacists the opportunity to obtain the practical experience
			 required for examination and licensure as a pharmacist.
(B) If a person is actively working towards
			 the requirements for licensure as a pharmacist and 
								seeks to work
			 as a pharmacy intern in Ohio, the person shall:
(1) Comply with at least one of the
			 following:
(a) Have successfully completed at
			 least sixty semester or ninety quarter hours of college, be enrolled in a
			 school of pharmacy, and has begun taking professional classes directly related
			 to the practice of pharmacy;
(b)
			 Have obtained a first professional degree in pharmacy from a program which has
			 been recognized and approved by the state board of pharmacy; or
(c) Have established educational equivalency
			 by obtaining a "Foreign Pharmacy Graduate Examination Commission (FPGEC)"
			 certificate and have established
			 proficiency in spoken English by successfully completing the "Test of English
			 as a Foreign Language, Internet-based test" (TOEFL iBT) pursuant to rule
			 4729:2-2-06 of the
			 Administrative Code.
Ohio Administrative Code › Title 4729:2 - Pharmacy Interns › Chapter 4729:2-2 - Licenses › Section 4729:2-2-02 - Application for licensure as a pharmacy intern

Current through all regulations passed and filed through July 1, 2024
(A) Each person seeking a license as a
			 pharmacy intern for the purpose of obtaining the practical experience required
			 for examination and licensure as a pharmacist shall submit the following to the
			 state board of pharmacy:
(1) A completed
			 application form as provided by the board, which can be accessed by visiting
http://www.pharmacy.ohio.gov
.
(2)
									Required fee.
(3) Documentation, in a
			 manner determined by the board, that the applicant has successfully completed a
			 minimum of sixty semester or ninety quarter hours of college work.
(4)
(a) Documentation, in a manner determined by
			 the board, from a school of pharmacy that has been recognized and approved by
			 the board certifying that the person is currently enrolled in a school of
			 pharmacy and has begun taking professional classes directly related to the
			 practice of pharmacy; or
(b) Either
			 of the following:
(i) Certification
			 provided by the national association of boards of
			 pharmacy documenting the applicant has obtained a first professional degree in pharmacy from a program
			 that has been recognized and approved by the state board of pharmacy;
			 or
(ii) Certification of having
			 established educational equivalency by obtaining a "Foreign Pharmacy Graduate
			 Examination Commission (FPGEC)" certificate, and evidence of successful
			 completion of the "Test of English as a Foreign Language, Internetbased test"
			 (TOEFL iBT) pursuant to rule
			 4729:2-2-06 of the
			 Administrative Code.
(5)
									Any other
			 information or documentation as determined by the board.
Ohio Administrative Code › Title 4729:2 - Pharmacy Interns › Chapter 4729:2-2 - Licenses › Section 4729:2-2-03 - Criminal records check for pharmacy interns

Current through all regulations passed and filed through July 1, 2024
(A)
								Pursuant to
			 section 4729.071 of the Revised Code, an
			 applicant seeking an initial license as a pharmacy intern must first submit
			 fingerprint impressions to the Ohio bureau of criminal identification and
			 investigation (BCI&I) for a criminal records check.
(B)
								Pursuant to
			 section 4776.02 of the Revised Code, the
			 criminal records check performed by BCI&I shall consist of both a BCI&I
			 criminal records check and a federal bureau of investigation (FBI) criminal
			 records check. BCI&I shall send the results of the BCI&I and FBI
			 criminal records checks directly to the state board of
			 pharmacy.
(C)
								The state board of pharmacy requires that the criminal
			 records check:
(1)
									Be based on electronic fingerprint impressions that are
			 submitted directly to BCI&I from a WebCheck provider agency or ink
			 impressions. The state board of pharmacy may accept the results of a criminal
			 records check based on ink impressions only in the following
			 circumstances:
(a)
										Readable electronic fingerprint impressions cannot be
			 obtained or are rejected by either BCI&I or FBI;
(b)
										The applicant is
			 from out-of-state;
(c)
										The applicant's home address is seventy-five miles or
			 more from the nearest WebCheck location.